BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 26473392)

  • 1. Distinct clinical and pathological phenotypes in frontotemporal dementia associated with MAPT, PGRN and C9orf72 mutations.
    Snowden JS; Adams J; Harris J; Thompson JC; Rollinson S; Richardson A; Jones M; Neary D; Mann DM; Pickering-Brown S
    Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(7-8):497-505. PubMed ID: 26473392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frontotemporal lobar degeneration: Pathogenesis, pathology and pathways to phenotype.
    Mann DMA; Snowden JS
    Brain Pathol; 2017 Nov; 27(6):723-736. PubMed ID: 28100023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and genetic analysis of MAPT, GRN, and C9orf72 genes in Korean patients with frontotemporal dementia.
    Kim EJ; Kwon JC; Park KH; Park KW; Lee JH; Choi SH; Jeong JH; Kim BC; Yoon SJ; Yoon YC; Kim S; Park KC; Choi BO; Na DL; Ki CS; Kim SH
    Neurobiol Aging; 2014 May; 35(5):1213.e13-7. PubMed ID: 24387985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analyses MAPT, GRN, and C9orf72 mutations in Chinese patients with frontotemporal dementia.
    Tang M; Gu X; Wei J; Jiao B; Zhou L; Zhou Y; Weng L; Yan X; Tang B; Xu J; Shen L
    Neurobiol Aging; 2016 Oct; 46():235.e11-5. PubMed ID: 27311648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort.
    Van Mossevelde S; van der Zee J; Gijselinck I; Engelborghs S; Sieben A; Van Langenhove T; De Bleecker J; Baets J; Vandenbulcke M; Van Laere K; Ceyssens S; Van den Broeck M; Peeters K; Mattheijssens M; Cras P; Vandenberghe R; De Jonghe P; Martin JJ; De Deyn PP; Cruts M; Van Broeckhoven C;
    Brain; 2016 Feb; 139(Pt 2):452-67. PubMed ID: 26674655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Features of MAPT, GRN, C9orf72 and CHCHD10 Gene Mutations in Chinese Patients with Frontotemporal Dementia.
    Che XQ; Zhao QH; Huang Y; Li X; Ren RJ; Chen SD; Wang G; Guo QH
    Curr Alzheimer Res; 2017; 14(10):1102-1108. PubMed ID: 28462717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics.
    Whitwell JL; Weigand SD; Boeve BF; Senjem ML; Gunter JL; DeJesus-Hernandez M; Rutherford NJ; Baker M; Knopman DS; Wszolek ZK; Parisi JE; Dickson DW; Petersen RC; Rademakers R; Jack CR; Josephs KA
    Brain; 2012 Mar; 135(Pt 3):794-806. PubMed ID: 22366795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain atrophy over time in genetic and sporadic frontotemporal dementia: a study of 198 serial magnetic resonance images.
    Whitwell JL; Boeve BF; Weigand SD; Senjem ML; Gunter JL; Baker MC; DeJesus-Hernandez M; Knopman DS; Wszolek ZK; Petersen RC; Rademakers R; Jack CR; Josephs KA
    Eur J Neurol; 2015 May; 22(5):745-52. PubMed ID: 25683866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation Frequency of the Major Frontotemporal Dementia Genes, MAPT, GRN and C9ORF72 in a Turkish Cohort of Dementia Patients.
    Guven G; Lohmann E; Bras J; Gibbs JR; Gurvit H; Bilgic B; Hanagasi H; Rizzu P; Heutink P; Emre M; Erginel-Unaltuna N; Just W; Hardy J; Singleton A; Guerreiro R
    PLoS One; 2016; 11(9):e0162592. PubMed ID: 27632209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study.
    Moore KM; Nicholas J; Grossman M; McMillan CT; Irwin DJ; Massimo L; Van Deerlin VM; Warren JD; Fox NC; Rossor MN; Mead S; Bocchetta M; Boeve BF; Knopman DS; Graff-Radford NR; Forsberg LK; Rademakers R; Wszolek ZK; van Swieten JC; Jiskoot LC; Meeter LH; Dopper EG; Papma JM; Snowden JS; Saxon J; Jones M; Pickering-Brown S; Le Ber I; Camuzat A; Brice A; Caroppo P; Ghidoni R; Pievani M; Benussi L; Binetti G; Dickerson BC; Lucente D; Krivensky S; Graff C; Öijerstedt L; Fallström M; Thonberg H; Ghoshal N; Morris JC; Borroni B; Benussi A; Padovani A; Galimberti D; Scarpini E; Fumagalli GG; Mackenzie IR; Hsiung GR; Sengdy P; Boxer AL; Rosen H; Taylor JB; Synofzik M; Wilke C; Sulzer P; Hodges JR; Halliday G; Kwok J; Sanchez-Valle R; Lladó A; Borrego-Ecija S; Santana I; Almeida MR; Tábuas-Pereira M; Moreno F; Barandiaran M; Indakoetxea B; Levin J; Danek A; Rowe JB; Cope TE; Otto M; Anderl-Straub S; de Mendonça A; Maruta C; Masellis M; Black SE; Couratier P; Lautrette G; Huey ED; Sorbi S; Nacmias B; Laforce R; Tremblay ML; Vandenberghe R; Damme PV; Rogalski EJ; Weintraub S; Gerhard A; Onyike CU; Ducharme S; Papageorgiou SG; Ng ASL; Brodtmann A; Finger E; Guerreiro R; Bras J; Rohrer JD;
    Lancet Neurol; 2020 Feb; 19(2):145-156. PubMed ID: 31810826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions.
    Simón-Sánchez J; Dopper EG; Cohn-Hokke PE; Hukema RK; Nicolaou N; Seelaar H; de Graaf JR; de Koning I; van Schoor NM; Deeg DJ; Smits M; Raaphorst J; van den Berg LH; Schelhaas HJ; De Die-Smulders CE; Majoor-Krakauer D; Rozemuller AJ; Willemsen R; Pijnenburg YA; Heutink P; van Swieten JC
    Brain; 2012 Mar; 135(Pt 3):723-35. PubMed ID: 22300876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p.
    Hsiung GY; DeJesus-Hernandez M; Feldman HH; Sengdy P; Bouchard-Kerr P; Dwosh E; Butler R; Leung B; Fok A; Rutherford NJ; Baker M; Rademakers R; Mackenzie IR
    Brain; 2012 Mar; 135(Pt 3):709-22. PubMed ID: 22344582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations.
    Snowden JS; Rollinson S; Thompson JC; Harris JM; Stopford CL; Richardson AM; Jones M; Gerhard A; Davidson YS; Robinson A; Gibbons L; Hu Q; DuPlessis D; Neary D; Mann DM; Pickering-Brown SM
    Brain; 2012 Mar; 135(Pt 3):693-708. PubMed ID: 22300873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The unexpected co-occurrence of GRN and MAPT p.A152T in Basque families: Clinical and pathological characteristics.
    Moreno F; Indakoetxea B; Barandiaran M; Caballero MC; Gorostidi A; Calafell F; Gabilondo A; Tainta M; Zulaica M; Martí Massó JF; López de Munain A; Sánchez-Juan P; Lee SE
    PLoS One; 2017; 12(6):e0178093. PubMed ID: 28594853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic signatures of genetic frontotemporal dementia.
    Rohrer JD; Warren JD
    Curr Opin Neurol; 2011 Dec; 24(6):542-9. PubMed ID: 21986680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic architecture of amyotrophic lateral sclerosis and frontotemporal dementia : Overlap and differences].
    Synofzik M; Otto M; Ludolph A; Weishaupt JH
    Nervenarzt; 2017 Jul; 88(7):728-735. PubMed ID: 28573364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A modified Camel and Cactus Test detects presymptomatic semantic impairment in genetic frontotemporal dementia within the GENFI cohort.
    Moore K; Convery R; Bocchetta M; Neason M; Cash DM; Greaves C; Russell LL; Clarke MTM; Peakman G; van Swieten J; Jiskoot L; Moreno F; Barandiaran M; Sanchez-Valle R; Borroni B; Laforce R; Doré MC; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Karnath HO; Vandenberghe R; de Mendonça A; Maruta C; Tagliavini F; Santana I; Ducharme S; Butler C; Gerhard A; Levin J; Danek A; Otto M; Warren JD; Rohrer JD;
    Appl Neuropsychol Adult; 2022; 29(1):112-119. PubMed ID: 32024404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations.
    Pickering-Brown SM; Rollinson S; Du Plessis D; Morrison KE; Varma A; Richardson AM; Neary D; Snowden JS; Mann DM
    Brain; 2008 Mar; 131(Pt 3):721-31. PubMed ID: 18192287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct clinical characteristics of C9orf72 expansion carriers compared with GRN, MAPT, and nonmutation carriers in a Flanders-Belgian FTLD cohort.
    Van Langenhove T; van der Zee J; Gijselinck I; Engelborghs S; Vandenberghe R; Vandenbulcke M; De Bleecker J; Sieben A; Versijpt J; Ivanoiu A; Deryck O; Willems C; Dillen L; Philtjens S; Maes G; Bäumer V; Van Den Broeck M; Mattheijssens M; Peeters K; Martin JJ; Michotte A; Santens P; De Jonghe P; Cras P; De Deyn PP; Cruts M; Van Broeckhoven C
    JAMA Neurol; 2013 Mar; 70(3):365-73. PubMed ID: 23338682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analyses of the MAPT, PGRN, and C9orf72 mutations in Japanese patients with FTLD, PSP, and CBS.
    Ogaki K; Li Y; Takanashi M; Ishikawa K; Kobayashi T; Nonaka T; Hasegawa M; Kishi M; Yoshino H; Funayama M; Tsukamoto T; Shioya K; Yokochi M; Imai H; Sasaki R; Kokubo Y; Kuzuhara S; Motoi Y; Tomiyama H; Hattori N
    Parkinsonism Relat Disord; 2013 Jan; 19(1):15-20. PubMed ID: 22818528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.